Poseida Therapeutics, Inc. Capital Expenditures
Poseida Therapeutics, Inc. reported Capital Expenditures of $1.79 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2024-11-07
- Poseida Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-09-30 was $645.00K, a 18.25% decline year-over-year.
- Poseida Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-06-30 was $1.02M, a 13.94% decline year-over-year.
- Poseida Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-03-31 was $130.00K, a 83.42% decline year-over-year.
- Poseida Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2023-12-31 was $309.00K, a 18.85% increase year-over-year.
- Poseida Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $3.07M, a 21.87% decline from fiscal 2022.
- Poseida Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $3.92M, a 48.97% increase from fiscal 2021.
- Poseida Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2021 was $2.63M, a 84.42% decline from fiscal 2020.
- Poseida Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2020 was $16.91M, a 227.93% increase from fiscal 2019.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2024-09-30 | $645.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.66M derived: sum of 2 quarters · filed 2024-11-07 | $1.79M 10-Q · filed 2024-11-07 | $2.10M derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | $1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $1.15M 10-Q · filed 2024-08-05 | $1.46M derived: sum of 3 quarters · filed 2024-08-05 | $2.25M derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-03-31 | $130.00K 10-Q · filed 2024-05-14 | $439.00K derived: sum of 2 quarters · filed 2024-05-14 | $1.23M derived: sum of 3 quarters · filed 2024-11-07 | $2.41M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-12-31 | $309.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $1.10M derived: sum of 2 quarters · filed 2024-11-07 | $2.28M derived: sum of 3 quarters · filed 2024-11-07 | $3.07M 10-K · filed 2024-03-07 |
| 2023-09-30 | $789.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.97M derived: sum of 2 quarters · filed 2024-11-07 | $2.76M 10-Q · filed 2024-11-07 | $3.02M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $1.97M 10-Q · filed 2024-08-05 | $2.23M derived: sum of 3 quarters · filed 2024-08-05 | $3.93M derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | $784.00K 10-Q · filed 2024-05-14 | $1.04M derived: sum of 2 quarters · filed 2024-05-14 | $2.75M derived: sum of 3 quarters · filed 2024-05-14 | $3.96M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $260.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $1.96M derived: sum of 2 quarters · filed 2024-03-07 | $3.18M derived: sum of 3 quarters · filed 2024-03-07 | $3.92M 10-K · filed 2024-03-07 |
| 2022-09-30 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $2.92M derived: sum of 2 quarters · filed 2023-11-09 | $3.66M 10-Q · filed 2023-11-09 | $3.88M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.96M 10-Q · filed 2023-08-08 | $2.17M derived: sum of 3 quarters · filed 2023-08-08 | $2.54M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $743.00K 10-Q · filed 2023-05-09 | $956.00K derived: sum of 2 quarters · filed 2023-05-09 | $1.32M derived: sum of 3 quarters · filed 2023-05-09 | $2.90M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $213.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $578.00K derived: sum of 2 quarters · filed 2023-03-09 | $2.16M derived: sum of 3 quarters · filed 2023-03-09 | $2.63M 10-K · filed 2023-03-09 |
| 2021-09-30 | $365.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.95M derived: sum of 2 quarters · filed 2022-11-10 | $2.42M 10-Q · filed 2022-11-10 | $4.57M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $2.06M 10-Q · filed 2022-08-11 | $4.21M derived: sum of 3 quarters · filed 2022-08-11 | $7.01M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $475.00K 10-Q · filed 2022-05-12 | $2.63M derived: sum of 2 quarters · filed 2022-05-12 | $5.43M derived: sum of 3 quarters · filed 2022-05-12 | $13.87M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $4.95M derived: sum of 2 quarters · filed 2022-03-10 | $13.39M derived: sum of 3 quarters · filed 2022-03-10 | $16.91M 10-K · filed 2022-03-10 |
| 2020-09-30 | $2.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $11.24M derived: sum of 2 quarters · filed 2021-11-09 | $14.76M 10-Q · filed 2021-11-09 | $16.14M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $8.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $11.96M 10-Q · filed 2021-08-12 | $13.34M derived: sum of 3 quarters · filed 2021-08-12 | $15.16M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $3.52M 10-Q · filed 2021-05-11 | $4.90M derived: sum of 2 quarters · filed 2021-05-11 | $6.72M derived: sum of 3 quarters · filed 2021-05-11 | |
| 2019-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $3.20M derived: sum of 2 quarters · filed 2021-03-11 | $5.16M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $1.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $3.77M 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $1.95M 10-Q · filed 2020-08-20 |